Is Kiniksa Pharmaceuticals Ltd. [KNSA] a good investment? Don’t be fooled by its recent momentum
In yesterday’s Wall Street session, Kiniksa Pharmaceuticals Ltd. (NASDAQ:KNSA) shares traded at $20.20, up 3.70% from the previous session. 5 analysts cover Kiniksa Pharmaceuticals Ltd. (NASDAQ:KNSA), according to research data. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $32.00 and a […]